The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call
The Oncology Institute (TOI), a leading value-based oncology group in the United States, has scheduled its first quarter 2025 financial results announcement. The company will release its Q1 2025 results after market close on Wednesday, May 14, 2025, followed by a conference call at 5:00 p.m. Eastern Time.
Investors can access the conference call via phone (1-877-407-0789 for domestic, 1-201-689-8562 for international) or through a simultaneous webcast on TOI's Investor Relations website. A replay will be available for one week until May 21, 2025, using passcode 13752832.
L'Istituto di Oncologia (TOI), un gruppo oncologico statunitense leader nel valore, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025. L'azienda pubblicherà i risultati del primo trimestre 2025 dopo la chiusura del mercato di mercoledì 14 maggio 2025, seguiti da una conference call alle 17:00 ora della costa orientale.
Gli investitori potranno partecipare alla conference call telefonicamente (1-877-407-0789 per il territorio nazionale, 1-201-689-8562 per l'internazionale) o tramite una diretta web sul sito Investor Relations di TOI. Una registrazione sarà disponibile per una settimana, fino al 21 maggio 2025, utilizzando il codice d’accesso 13752832.
El Instituto de Oncología (TOI), un grupo líder en oncología basado en el valor en Estados Unidos, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025. La compañía publicará los resultados del primer trimestre de 2025 después del cierre del mercado el miércoles 14 de mayo de 2025, seguido de una llamada conferencia a las 5:00 p.m., hora del Este.
Los inversores podrán acceder a la llamada conferencia por teléfono (1-877-407-0789 para llamadas nacionales, 1-201-689-8562 para internacionales) o a través de una transmisión simultánea en el sitio web de Relaciones con Inversionistas de TOI. La repetición estará disponible durante una semana, hasta el 21 de mayo de 2025, usando el código de acceso 13752832.
종양학 연구소(TOI)는 미국을 대표하는 가치 기반 종양학 그룹으로, 2025년 1분기 재무 실적 발표 일정을 확정했습니다. 회사는 2025년 5월 14일 수요일 장 마감 후 1분기 2025 실적을 발표하며, 이어서 동부 표준시 기준 오후 5시에 컨퍼런스 콜을 진행할 예정입니다.
투자자들은 전화(국내 1-877-407-0789, 국제 1-201-689-8562) 또는 TOI 투자자 관계 웹사이트에서 동시 웹캐스트를 통해 컨퍼런스 콜에 참여할 수 있습니다. 재청취는 2025년 5월 21일까지 1주일간 가능하며, 접속 코드는 13752832입니다.
L'Institut d'Oncologie (TOI), un groupe oncologique de premier plan axé sur la valeur aux États-Unis, a programmé l'annonce de ses résultats financiers du premier trimestre 2025. La société publiera ses résultats du T1 2025 après la clôture du marché le mercredi 14 mai 2025, suivis d'une conférence téléphonique à 17h00, heure de l'Est.
Les investisseurs pourront accéder à la conférence téléphonique par téléphone (1-877-407-0789 pour les appels nationaux, 1-201-689-8562 pour les appels internationaux) ou via une webdiffusion simultanée sur le site des Relations Investisseurs de TOI. Une rediffusion sera disponible pendant une semaine jusqu'au 21 mai 2025, avec le code d'accès 13752832.
Das Onkologie-Institut (TOI), eine führende wertorientierte Onkologiegruppe in den USA, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 geplant. Das Unternehmen wird die Ergebnisse des ersten Quartals 2025 nach Börsenschluss am Mittwoch, den 14. Mai 2025 veröffentlichen, gefolgt von einer Telefonkonferenz um 17:00 Uhr Eastern Time.
Investoren können an der Telefonkonferenz telefonisch teilnehmen (1-877-407-0789 für Inland, 1-201-689-8562 für Ausland) oder über einen gleichzeitigen Webcast auf der Investor-Relations-Website von TOI. Eine Wiederholung ist für eine Woche bis zum 21. Mai 2025 mit dem Zugangscode 13752832 verfügbar.
- None.
- None.
CERRITOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2025 financial results after the market close on Wednesday, May 14, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13752832. The replay will be available until Wednesday, May 21, 2025.
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
About The Oncology Institute
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better. For more information, visit www.theoncologyinstitute.com
Contacts
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com
FAQ
When will The Oncology Institute (TOI) release Q1 2025 earnings?
How can investors join TOI's Q1 2025 earnings call?
What is the replay information for TOI's Q1 2025 earnings call?
Where can I find TOI's Q1 2025 earnings webcast?
